CN100482258C - Bone meridian qi blood dredging medicine preparation - Google Patents

Bone meridian qi blood dredging medicine preparation Download PDF

Info

Publication number
CN100482258C
CN100482258C CNB2006101240506A CN200610124050A CN100482258C CN 100482258 C CN100482258 C CN 100482258C CN B2006101240506 A CNB2006101240506 A CN B2006101240506A CN 200610124050 A CN200610124050 A CN 200610124050A CN 100482258 C CN100482258 C CN 100482258C
Authority
CN
China
Prior art keywords
blood
medicine preparation
medicine
bone
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006101240506A
Other languages
Chinese (zh)
Other versions
CN1985938A (en
Inventor
郑述章
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006101240506A priority Critical patent/CN100482258C/en
Publication of CN1985938A publication Critical patent/CN1985938A/en
Application granted granted Critical
Publication of CN100482258C publication Critical patent/CN100482258C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The bone meridian qi blood dredging medicine preparation consists of 10 kinds of Chinese medicinal materials, including dragon's blood, frankincense, myrrh, cassia twig, corydalis tuber, etc as well as tetracycline, analgin and prednisone in certain weight proportion. The medicine has high curative rate, quick acting, wide action range, low production cost and other advantages.

Description

Bone meridian qi blood dredging medicine preparation
Technical field
The present invention relates to the disease treatment field of pharmaceutical technology, refer in particular to that a kind of treatment gram positive bacteria infection, gram positive bacterial infection, osteomyelitis, femur head necrosis, fracture, periostitis, cartilage injury, rheumatic arthritis, spondylitis, scapulohumeral periarthritis, hyperosteogeny, redness and swelling of joints, arthralgia, vertebra point dish are outstanding, benign tumor, congestion pain, lump, old muscle injury, gynecological, genital system infection; Abdominal part regulating liver-QI, the infection of gallbladder system, head congestion pain etc. are stopped up the bone meridian qi blood dredging medicine preparation of the disease that is caused because of QI and blood.
Background technology
In the market, with in this product effect similarly, the Western medicine product [for example: pefloxacin mesilate sheet (the accurate word H10950210 of traditional Chinese medicines). cefalexin trimethoprim capsule (the accurate word H22025450 of traditional Chinese medicines). tanshinone capsule (the accurate word Z13020110 of traditional Chinese medicines)] mainly have a following shortcoming and defect:<1〉cost an arm and a leg, and content is few, can't be as the good medicine of chronic's life-time service.<2〉effect: though act on widely, use symptom many, only good to some antibacterial or disease effects, not good enough for most of bacterioids or disease effects.<3〉the forbidding condition is too many.The probability that too many forbidding condition makes the patient accept the medicine treatment reduces.<4〉bad reflection is too many.<5〉therapeutic efficiency: to multiplicity bacterial infection poor effect or not good enough, and need take for a long time some antibacterial (disease) effect, very big to patient's economic pressures.
Summary of the invention
The object of the present invention is to provide a kind of fast, efficient, cure rate is high, therapeutic domain is wide and low-cost production, manufacturing process is simple, side effect is little, low-cost bone meridian qi blood dredging medicine preparation.
Technical scheme provided by the invention for achieving the above object is: contain following ingredient: Sanguis Draxonis 220 to 280g, Olibanum 70g is to 130g, and Myrrha 70g is to 130g, and Ramulus Cinnamomi 70g is to 130g, Rhizoma Corydalis 70g is to 130g, Rhizoma Chuanxiong 70g is to 130g, and Radix Angelicae Sinensis 70g is to 130g, and Radix Codonopsis 70g is to 130g, Rhizoma Atractylodis Macrocephalae 70g to 130g with burning the defocused Fructus Toosendan 70g of crust that removes to 130g, tetracycline 124g is to 164g, and dipyrone 220 arrives 280g, and prednisone (another name prednisolone acetate) 3000mg is to 3500mg.
Prescription of the present invention is the symptom of the process of the cause of disease, development at described disease and disease and the medicine formulated, by the silt of invigorating blood circulation, expelling wind and cold, dehumidifying blood stasis dispelling, bone and muscle strengthening, heat-clearing and toxic substances removing, blood-activating and qi-promoting, blood stasis dispelling be logical to stagnate, removing the necrotic tissue and promoting granulation, reducing swelling and alleviating pain and the therapeutic process of dispeling the cause of disease, reach and eliminate a disease recovery human body (other animal body) normal physiological function.Plain statement both this prescription by gastrointestinal absorption, is distributed to whole body rapidly after patent medicine entered human body (other animal body).The medicine effective element with blood flow through liver.The hepatic secretion drug metabolism enzyme, drug metabolism enzyme and the decomposition of medicine effective element synthesize the factor of invigorating blood circulation.Invigorate blood circulation the factor with blood flow, flow to behind the lesions position and the reflection of Production by Bacteria crude drug thing.The factor of invigorating blood circulation can suppress and eliminating bacteria because of having germ-resistant effect, makes the lesions position physiological function recover normal.Toxin (antibacterial after the death) to kidney, divides toxolysin through kidney with blood flow, and toxin just excretes with urine.
As lift the healing principle of case-this prescription to chronic osteomyelitis: osteomyelitis is after entering bone marrow by a large amount of antibacterials by blood flow, to cause the bone marrow local inflammation, and damage local sclerotin, destroys the lesions position blood circulation.Because the protection of bone marrow barrier, so general medicine can't pass through the bone marrow barrier, thereby osteomyelitis is difficult to cure.Good as local blood fortune, even infection is arranged, body has defense function to antibacterial, and inflammation also can disappear rapidly, and the antibiotic of input also reaches osteopathia kitchen range portion easily and brings into play effectiveness.The pathological characters of chronic osteomyelitis is exactly the local blood fortune that lacks, and therefore, thereby antibiotic can not thoroughly enter lesions position treatment inflammation.Though it is not antibiotic clinical practice is very effective to the treatment of acute osteomyelitis, no matter is oral or the intravenous injection antibiotic, just so obvious to chronic osteomyelitis.Because the osseous tissue focus of chronic osteomyelitis is destroyed, necrosis, the surrounding tissue ischemia, local blood fortune lacks, and antibiotic can not effectively arrive focus, and this is the main cause of osteomyelitis refractory.Because Chinese medicine is better to improving ischemia phenomenon effect, fastbacteria there is good efficacy.The effective element that this prescription had arrives inflammation part by blood flow, after improving ischemia,, make a large amount of dead and inhibition of antibacterial with the reflection of Production by Bacteria crude drug reason, play the effect of anti-inflammation detumescence, make partial inflammation elimination and eliminating bacteria and improve local blood fortune.The characteristics of this medicine are to have very strong permeability (this prescription has a large amount of elements of invigorating blood circulation), can arrive lesions position (passing through the bone marrow barrier) smoothly, thereby osteomyelitis is had efficient and unique effect.
Explain from the angle of the traditional Chinese medical science: all causes of disease all are because disorder of QI and blood causes QI and blood to be become silted up and hinders, and causes pathological changes.Medicine in this prescription is according to the record of Compendium of Material Medica, and wherein Rhizoma Chuanxiong, Radix Angelicae Sinensis, Sanguis Draxonis, Olibanum, Myrrha contain a large amount of factors of invigorating blood circulation.Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae have the function of increase blood circulation (QI invigorating).Rhizoma Corydalis, Fructus Toosendan have circulation of qi promoting, pain relieving and repercussive effect.Ramulus Cinnamomi has the contractility that increases heart, strengthens the effect of blood pressure.The principles of chemistry and qi as the commander of blood in line with this prescription drug composition itself, the capable principle of the capable then blood of gas, this prescription has just possessed the extremely strong silt of invigorating blood circulation, expelling wind and cold, dehumidifying blood stasis dispelling, and pharmacological action stagnant, removing the necrotic tissue and promoting granulation is led in bone and muscle strengthening, reducing swelling and alleviating pain, thin channels and activating collaterals, heat-clearing and toxic substances removing, blood-activating and qi-promoting, blood stasis dispelling.
Put down in writing according to " closing five kinds in Xin Shi medical book ": tetracycline is a broad-spectrum antibacterial agent, tool bactericidal action during high concentration.Except common gram positive bacteria, gram-negative bacteria and anaerobe, most rickettsiaes, Mycoplasma, chlamydiaceae, anonymous mycobacteria genus, spirillum are also to sensitive tetracycline.Dipyrone has antipyretic-antalgic and non_steroidal anti_inflammatory drug.Prednisone (another name prednisolone acetate) Aeroseb-Dex has antiinflammatory, antiallergic, rheumatism, immunosuppressive action.
The invention has the advantages that: 1, price is very cheap, takes 1 at every turn, one day three times.And each gram cost of raw material only needs 0.09 yuan of RMB.And effect and effect just can reach best.Make the blood of human body (other animal body) have effective element in the ingredient of the present invention for a long time, for a long time to the effect of the carrier cause of disease, and it is fast, effective and lasting to repair sick body, treatment disease and therapeutic efficiency.2 under equivalent weight, and this product cost is all low than the similar cost of drugs of effect on the existing market.2, therapeutic domain is wide, and the disease of being treated comprises:, benign tumor outstanding to gram positive bacteria infection, gram positive bacterial infection, osteomyelitis, femur head necrosis, fracture, periostitis, cartilage injury, rheumatic arthritis, spondylitis, scapulohumeral periarthritis, hyperosteogeny, redness and swelling of joints, arthralgia, vertebra point dish, congestion pain, lump, old muscle injury, gynecological, genital system infection; Abdominal part regulating liver-QI, the infection of gallbladder system, head congestion pain etc. are stopped up the disease that is caused because of QI and blood and are all had very outstanding therapeutic effect.3, few side effects only can reduce a little immunocompetence of human body.Other can not appear to human body incompatibility symptom, and littler than product sold on the existing market to the injury of human body.4, the forbidding condition is few, and just the anemia of pregnant woman is forbidden, the neonate forbidding.
The specific embodiment:
Prescription: Sanguis Draxonis 250g, Olibanum 100g, Myrrha 100g, Ramulus Cinnamomi 100g, Rhizoma Corydalis 100g, Rhizoma Chuanxiong 100g, Radix Angelicae Sinensis 100g, Radix Codonopsis 100g, Rhizoma Atractylodis Macrocephalae 100g, Fructus Toosendan (with burning the defocused crust that removes) 100g, tetracycline 150g, dipyrone 250g, prednisone (another name prednisolone acetate) 3500mg.
Will on chat component and be made into powder, encapsulated, every 0.4g or 0.6g.The each 0.4g of child, each 0.6g.. that is grown up is oral, one day three times.
, various pain outstanding, various benign tumor, various congestion pain, lump, old muscle injury, gynecological, genital system infection to treatment gram positive bacteria infection, gram positive bacterial infection, osteomyelitis, femur head necrosis, fracture, periostitis, cartilage injury, rheumatic arthritis, spondylitis, scapulohumeral periarthritis, hyperosteogeny, redness and swelling of joints, arthralgia, vertebra point dish; Abdominal part regulating liver-QI, the infection of gallbladder system, head congestion pain etc. are stopped up the disease that is caused because of QI and blood.Have optimum efficiency. good to analgesic effect, but be not suitable for having moon bright open sore part patient. the therapeutic efficiency height. because prednisone belongs to hormone medicine, the effective ingredient snap action that helps this prescription is in the cause of disease.
If there is pyogenic infection in the patient, need to deduct prednisone (another name prednisolone acetate) according to above-mentioned prescription.But the prescription that does not contain prednisone is applicable to and contains above disease the patient who has pyogenic infection, and paroxysmal pain is effective.(another name prednisolone acetate) belongs to hormone medicine because prednisone, and patient's suppurative focus is had a little side effect, can increase affected area and suppurate.
If there is not the pain phenomenon in the patient, can not need to add tetracycline, dipyrone.But need to add prednisone, this prescription helps to reduce the medicine cost, and the therapeutic efficiency that increases medicine is arranged.Perhaps need not to add prednisone, also good to treatment no pain, no suppuration patient effect, but the therapeutic efficiency minimizing.
Case: the applicant has femur head necrosis concurrently because of suffering from the concurrent osteomyelitis of acute moon bright poison septicemia (gold-coloured staphylococci), after take this prescription (Sanguis Draxonis 250g, Olibanum 100g, Myrrha 100g, Ramulus Cinnamomi 100g, Rhizoma Corydalis 100g, Rhizoma Chuanxiong 100g, Radix Angelicae Sinensis 100g, Radix Codonopsis 100g, Rhizoma Atractylodis Macrocephalae 100g, with defocused Fructus Toosendan 100g, tetracycline 150g, dipyrone 250g, the prednisone 3500mg that removes crust of baked wheaten cake.) medicine, through the treatment of half a year, osteomyelitis, femur head necrosis are cured.

Claims (2)

1, bone meridian qi blood dredging medicine preparation, it is characterized in that: contain following ingredient: Sanguis Draxonis 220 to 280g, Olibanum 70g is to 130g, and Myrrha 70g is to 130g, and Ramulus Cinnamomi 70g is to 130g, Rhizoma Corydalis 70g is to 130g, Rhizoma Chuanxiong 70g is to 130g, and Radix Angelicae Sinensis 70g is to 130g, and Radix Codonopsis 70g is to 130g, Rhizoma Atractylodis Macrocephalae 70g is to 130g, with burning the defocused Fructus Toosendan 70g of crust that removes to 130g.
2, bone meridian qi blood dredging medicine preparation according to claim 1 is characterized in that: also contain in the following ingredients one or more: tetracycline 124g is to 164g, dipyrone 220 to 280g, and prednisone 3000mg is to 3500mg.
CNB2006101240506A 2006-12-05 2006-12-05 Bone meridian qi blood dredging medicine preparation Expired - Fee Related CN100482258C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101240506A CN100482258C (en) 2006-12-05 2006-12-05 Bone meridian qi blood dredging medicine preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101240506A CN100482258C (en) 2006-12-05 2006-12-05 Bone meridian qi blood dredging medicine preparation

Publications (2)

Publication Number Publication Date
CN1985938A CN1985938A (en) 2007-06-27
CN100482258C true CN100482258C (en) 2009-04-29

Family

ID=38182967

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101240506A Expired - Fee Related CN100482258C (en) 2006-12-05 2006-12-05 Bone meridian qi blood dredging medicine preparation

Country Status (1)

Country Link
CN (1) CN100482258C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644876A (en) * 2015-03-12 2015-05-27 肖冻 Traditional Chinese medicine preparation for treating periostitis caused by sports fatigue

Also Published As

Publication number Publication date
CN1985938A (en) 2007-06-27

Similar Documents

Publication Publication Date Title
CN104173937A (en) Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof
CN101569739B (en) Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof
CN100348235C (en) Chinese preparation for treating infantile diarrhea and its making method thereof
CN101966295A (en) Medicament for treating chronic amygdalitis
CN101167991A (en) Burn and scald treating ointment
CN100482258C (en) Bone meridian qi blood dredging medicine preparation
CN101979031A (en) Medicament for treating hemorrhoids and preparation method thereof
CN101530516B (en) Chinese medicament for treating appendicitis
CN100364595C (en) Compound Chinese herbal medicine of fossil, and preparation method
CN101829188B (en) Medicament for treating urinary infection and lithiasis
CN105079332A (en) Traditional Chinese medicine composition for treating perianal abscess caused by fire toxin accumulation
CN1270755C (en) Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis
CN104491418A (en) Traditional Chinese medicinal preparation for treating ulcerative colitis
CN104324201A (en) Traditional Chinese medicine preparation for treating urinary system infection and production method
CN103690654A (en) Pharmaceutical composition for treating infantile diarrhea
CN104491297B (en) A kind of Chinese medicine composition for treating palindromic urinary tract infection
CN113491739B (en) Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof
CN103520638B (en) A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof
CN102626491B (en) Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion
CN101822753A (en) Medicine for treating prostatitis and preparation method thereof
CN104958631A (en) Pharmaceutical composition for treating kidney stones and preparation method of pharmaceutical composition
CN105497267A (en) Traditional Chinese medicine composition for treating extreme noxious heat type infantile jaundice
CN104857262A (en) Pure Chinese material medicine preparation for treating knife wounds and postoperative pyogenic infection
CN105287838A (en) Traditional Chinese medicine formula used for treatment skin dry-dampness pruritus
CN104997916A (en) Traditional Chinese medicine treating urethritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090429

Termination date: 20111205